This role in US Clinical Development and Medical Affairs, will report directly to the VP, US CDMA Hematology. The US CDMA Oncology organization is responsible for all phase I-IV oncology clinical programs. He/she will provide strategic medical and scientific leadership for development-stage compound/s. The successful candidate will direct US clinical activities Providing medical input into clinical trial strategies. Develop the clinical strategy and plan to integrate Novartis Oncology compound/s into standard oncology practice. Work cross-functionally to define, plan and implement exploratory studies. Analyze data from clinical trials and produce reports as indicated. Participate in strategic planning as part of Development or Global Oncology teams where appropriate. Extensive interactions with academic thought leaders to optimize clinical trial strategies.
Successful candidate should have an MD Board Certified or board eligible in either Hematology or Oncology. English Two + years of Hematology/Oncology clinical research experience in the pharmaceutical industry OR experience in clinical research or medical affairs is preferable or a combination of experience in academic medicine with clinical research and or 1 year of clinical development experience in collaboration with the pharmaceutical industry. Scientific medical research experience in Oncology and or Hematology with demonstrated record of scientific medical publications. Experience leading the design, conduct, analysis and reporting of oncology clinical studies is strongly preferred. Position to be filled with level commensurate with experience. Novartis is an EEO/AA employer M/F/D/V.